Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — Study Shows Marijuana Helps Cancer Patients Manage Pain

According to a recent Canadian study, medical marijuana may be able to lessen cancer patients’ dependence on other medications by easing their discomfort. The study, published in “BMF Palliative and Supportive Care,” involved the examination of 358 cancer patients and concluded that cannabis could be safely combined with other medications to help in pain management.

Every three months, the researchers checked on the patients to see how much pain they were in and how many medications they were taking. Patients reported substantially less pain after using the cannabis-based medications and that their pain had less of an impact on their daily lives.

According to the study, one-third of cancer patients — about 38% — experience medium-to-high-level pain even after taking pain medications such as opioids. In particular, 66% of patients with metastatic, advanced or terminal illnesses, as well as 55% of patients receiving anticancer treatment, experience pain.

Additionally, the majority of patients report feeling nauseous, drowsy, constipated and — more seriously — restrained breathing. For these reasons, patients are increasingly asking doctors, including up to 61.5% of general practitioners, to consider medical marijuana for the treatment of pain and other symptoms related to cancer.

In the study, 38% of the patients used THC-CBD-balanced medications, 17% used CBD-dominant medicines, and nearly a quarter of the patients used THC-dominant products. Those who consumed THC-CBD-balanced products experienced less pain compared to patients who only used THC- or CBD-dominant products.

However, the researchers noted that the results need to be confirmed by more thorough studies that compare the effects of cannabis-based medications with those of a placebo in a control group.

There is a lot of interest in cannabis’ ability to relieve pain, particularly in light of the opioid epidemic that has sparked concerns about the long-term dangers of opiate addiction. In support of this, a large body of research has demonstrated a correlation between decreased opioid prescribing and overdose fatalities and legalized marijuana use. A study by the University of Colorado published last month indicated that regular marijuana usage is linked to better cognition and less pain in chemotherapy and cancer patients. Researchers discovered that patients who consumed products with higher CBD levels experienced less pain than those who used high-THC goods.

According to research conducted by the American Medical Association (AMA) and released earlier this year, people with chronic pain who used medical cannabis for more than a month had their need for opioids significantly reduced. Late last year, the AMA also published studies showing a link between legalized cannabis in some states and reduced opioid prescriptions for some cancer patients.

This study highlighting the pain-fighting potential of marijuana suggests that companies that are working to develop THC-based medications for chronic pain, such as IGC Pharma Inc. (NYSE American: IGC), are likely to be successful in their R&D efforts.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Oregon Secretary of State Resigns Due to Cannabis Consultancy Job

Last week, Shemia Fagan resigned as Oregon Secretary of State after receiving significant criticism for taking up a job as a consultant to a cannabis company while her office was concluding an audit of the state’s Liquor and Cannabis Commission. During her announcement, Fagan apologized for working for the business, pointing out that while she had planned to finish her term, it had been an honor to serve the people of Oregon.

She also highlighted that ethics guidelines permitted outside employment, noting that consulting for La Mota wasn’t a conflict of interest as any actions taken on account of the audit would be by the cannabis commission, legislature or governor. Fagan added that any changes in regulation would have also affected many businesses, not just her client. However, she continued, she had exercised poor judgment by working with a business regulated by an entity under audit by her division.

The consulting job is said to have paid her $10,000 a month, with added bonuses for every license she assisted the affiliate of La Mota acquire outside Oregon.

The salary of the secretary of state stands at $77,000 per annum, a low sum, particularly for the office’s tasks, which include auditing state agencies and overseeing elections. Results of the audit, which were released the week before, demanded that the state’s cannabis regulatory agency make changes to some of the rules for cannabis businesses.

Fagan isn’t the first to resign or leave the secretary of state post in Oregon. In fact, two recent secretaries have vacated their four-year term — one because of a death in office and one because the governor resigned and was replaced by the secretary of state. A successor to Fagan will be appointed by Governor Tina Kotek, who stated that she supported Fagan’s decision to resign from her elected office.

Following Fagan’s resignation announcement, Democratic leaders in the legislature released a joint statement declaring that Fagan needed to go. Those leaders included Senate Majority Leader Kate Lieber, Senate President Rob Wagner, House Speaker Dan Rayfield and House Majority Leader Julie Fahey. The statement noted that Fagan’s serious lapses of judgment had destroyed trust with the residents of Oregon, including lawmakers who depended on the work of the Audits Division for important information on public policy. They observed that her resignation would allow the state to rebuild trust and move forward.

Prior to being elected to the position in 2020, Fagan served as a Democratic member of the Oregon Senate.

As the marijuana industry continues its growth trajectory and blips such as this one are avoided, more cultivators will join the space to meet the growing demand for marijuana. By extension, more cultivation equipment, such as the microgardens commercialized by enterprises such as Advanced Container Technologies Inc. (OTC: ACTX), will be sold and revenues earned.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lift 2023 Event to Return to the Heart of Downtown Toronto

Lift Events & Experiences, Canada’s No. 1 cannabis conference and trade show series, today announced its return to the Metro Toronto Convention Centre (“MTCC”), a top-of-class venue for business event organizers, located in the heart of downtown Toronto. Lift Toronto 2023, slated to take place on June 1-3, is expected to attract representatives from more than 150 companies within the cannabis-value chain, 140+ renowned industry thought leaders, and 3,000 to 5,000 growers, licensed producers, retailers, budtenders, investors and consumers. As a fifth year of cannabis legalization in Canada comes to fruition, the event will commence with the full-day Lift Cannabis Business Conference (“LCBC”). The country’s premier business strategy conference, LCBC features an ideal platform to connect industry peers with managerial leaders, innovators, regulators, investors, researchers, suppliers and professional services. The LCBC, through a host of strategy-focused, advocacy-oriented, truth-to-power, business and industry leadership sessions, will chart the next steps for an industry that is targeting sustainable growth at home and around the world.

To view the full press release, visit https://cnw.fm/n7WPT

About Lift Events & Experiences

Lift Events & Experiences, known for Canada’s number-one cannabis industry conferences and trade shows, is expanding across the continent. Dedicated to honoring the legacy of the cannabis industry, Lift welcomes everyone, from craft growers to multistate operators to everyday folks who enjoy and respect the plant. Lift Events & Experiences is proudly managed by MCI Events.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Results of 2023 Annual Meeting

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the results of the 2023 Annual Meeting. According to the update, the company held the meeting at 1:00 p.m. PT on May 9, 2023, whereby there were 3,372,024 shares of the company represented in person or by proxy, constituting 56.3% of the company’s issued share capital as of the meeting date of March 13, 2023. The matters voted upon and the final voting results are set forth as detailed in the announcement. All proposals are described in detail in Lexaria’s proxy statement filed with the Securities Exchange Commission via Edgar and with the BC Securities Commission and Ontario Securities Commission via SEDAR on March 22, 2023.

To view the full press release, visit https://cnw.fm/Zkl8k

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 30 patents granted and many patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

2023 Alternative Products Expo, Medellin, to Network and Expand Your Business in a Single Comprehensive Event

Professionals, retailers, distributors, and enthusiasts are invited to attend the one-of-a-kind Alternative Products Expo to be held in Medellin, Colombia, from May 20-21, 2023. It’s a uniquely all-inclusive event that brings together the multi-billion-dollar alternative products industry into one comprehensive setting.

Every mainstream product has an alternative counterpart. The Alternative Products Expo is the one-stop destination to meet the prominent counterculture manufacturers and take advantage of the latest innovations and trends, show discounts, and network in the industry. By bringing the alternative community together, the expo seeks to provide industry professionals with a unique and immersive opportunity for business expansion and networking.

The Alternative Products Expo will feature all the advanced products that are disrupting the traditional markets. This innovative business networking event has expanded its show to include a wider range of alternative products, such as dietary supplements, kratom, nootropics, mushrooms, vapes & nicotine replacements, hemp derivatives, energy beverages, and more.

The Largest Expo Of Hemp, Vape, and Counterculture

ALT PRO Expo redefines the tradeshow experience by including a unique vibe that makes this an exciting event for any adult audience. With a vibrant and fun atmosphere, this event is designed to provide an exciting experience to meet the leading counterculture manufacturers, discover new product innovations, get updated on industry trends, and find the best show-exclusive deals.

The event is the ultimate gathering for independent retailers, smoke shop owners, buyers, and counterculture enthusiasts. Increasingly known for its pleasant climate and warm people, Medellin is an evolving tourism and business hub boasting the perfect landscape and incredible vibe for companies to make an impact. Alternative Products Expo is a B2B and B2C networking event for disruptive industries such as hemp-derived products, non-psychoactive mushrooms, nutraceuticals, semi-synthetic extracts, functional beverages, delta8, kratom, nicotine alternatives, and many more.

Network with over 400 vendors bringing the industry’s best brands.
Learn from expert speakers sharing knowledge and industry insights.
Find exclusive opportunities to buy innovative products at special prices.
Discover innovative products which your business could take to a mainstream audience.

To learn more, please visit https://cnw.fm/1KlA8. and https://cnw.fm/zBCcZ.

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/Disclaimer

Do you have a questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Department in California Gives Universities $20M to Study Cannabis

The California Department of Cannabis Control (DCC) revealed that on April 26, 2023, it had given 16 educational institutions funding totaling $19,942,918 for marijuana research. The funds will support projects researching how marijuana affects young people’s psychological wellness, innovative cannabinoids such as Delta-8 and Delta-10 THC, and a groundbreaking study of California’s historic cannabis genetics.

The DCC expects these activities will set the standard for marijuana research and enhance scientific study to better comprehend cannabis’ advantages and drawbacks.

Six divisions of colleges received awards, with Cal Poly Humboldt receiving the largest award of $2,699,178 for its grassroots study on heritage cannabis genetics. Additionally, $2 million each were given to the universities of California, Los Angeles, and Irvine to research the potency of marijuana. The first double-blind, federally acceptable, placebo-controlled drug administration trial comparing the consequences of inhaled marijuana plants to inhaled extracts will also be carried out through a partnership involving UC Irvine and UCLA.

The awards were given out based on their capacity to produce fundamental research that will underpin expanding future knowledge, their capability to enhance the public’s comprehension of marijuana, their potential to deliver information beneficial for legislation, and their solid scientific approach. Sixteen concepts were selected from a list of 98 total submissions.

The DCC also unveiled a brand-new funding initiative in February, promising $20 million to boost and develop the state’s marijuana business. The retail access grant program aims to promote legal retail businesses in locations where existing customers do not have easy access to legally grown marijuana.

Last year, the department executed 155 warrants for search operations, an increase from 61 in 2021, based on the report issued by the DCC at the beginning of March. The DCC captured an estimated 41,726 pounds of marijuana in 2021, with a market value of almost $78 million. In 2022, the amount rose to 144,254 pounds, with a value of more than $243 million.

In general, the DCC’s funding program aims to increase security for customers, foster an equitable market and increase the availability of California’s retail marijuana market. The DCC is eager to share the findings after the research is finished since the awards will offer insightful information on issues that concern Californian’s consumers, businesses, and legislators.

The program is designed to provide funding for research projects that address gaps in knowledge and understanding of the marijuana industry. It is hoped that this will lead to better regulation and policymaking in the future.

These studies funded by the DCC in California will add to the work being done by companies such as IGC Pharma Inc. (NYSE American: IGC), which lean more toward conducting research with the aim of commercializing marijuana-derived FDA-approved formulations.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Startups Leverage AI to Keep Competitive

The dawn of AI is here, with more and more sectors adopting the use of this technology to improve efficiency, optimize the growth process of businesses, and assist in making faster and more informed decisions. The cannabis industry has not been left behind, with more companies adopting this technology.

For instance, Green Rush Consulting recently launched a chatbot that specifically caters to the needs of the cannabis industry. For more than a decade, this consulting firm helped marijuana entrepreneurs acquire licenses using human consultants.

Zeta Ceti gained inspiration from ChatGPT, leading to the development of Oddysee AI, which can do about 70% of the work on marijuana licensing. Ceti, who showcased the product at a cannabis conference in Manhattan recently, revealed that the remaining 30% would be done by humans.

Jason Rosenberg, cofounder of Oddysee AI, explained how the product would direct users to a cannabis brand by names in their search. Oddysee AI is only one among many other startups in marijuana AI. A Toronto-based company, Predictmedix, is developing a program to test for marijuana impairment.

Little Dragon, a delivery-only business that specializes in high-THC products, also recently launched an AI program on an equity crowdfunding platform. Rachel Figueras, the cofounder of Little Dragon Dabs, revealed that its AI could learn a user’s preferences and assist them in choosing products better than a person would.

While it is expected that more players in the industry will follow suit as the adoption of AI grows, the results will vary due to the difference in regulations in states that have legalized some form of marijuana. Additionally, the increased adoption of this technology in the industry may put licensing consultants, budtenders and other participants out of business.

There are upsides to the technology’s use, however, including the issues it could solve, such as impaired driving. Predictmedix revealed that it utilized multispectral cameras to conduct an analysis of physiological data patterns and identify impairment, regardless of whether that impairment was induced by marijuana, alcohol or even mental illness.

In a statement, Dr. Rahul Kushwah, COO of Predictmedix, added that impairment testing by AI could be stepped up to accommodate higher numbers, which would in turn increase its usefulness for mass-testing scenarios such as workplace screenings and roadside checkpoints. Standardized labeling and testing is also another issue AI can solve, as highlighted by ChatGPT. However, more scientific data and studies are needed on the effects of marijuana in order to make these tools more effective.

As artificial intelligence tools help customers make better product choices, the market could become more sophisticated as buyers become drawn to products made from plants that show evidence of superior genetics, better cultivation methods (organic vs. plants grown using synthetic agrochemicals, for example). This attention to the way cannabis is grown may create extra demand for modern cultivation equipment from the likes of Advanced Container Technologies Inc. (OTC: ACTX) as growers seek to harvest superior yields.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Alternative Products Expo Slated to Return to Medellín for Upcoming Two-Day Event

The Alternative Products Expo, produced by ZJ Events, is being held this year for two days in Medellín, Colombia. Slated for May 20–21, 2023, the conference will feature an estimated 200 companies exhibiting more than 1,000 products in the alternative products space. Medellín, which hosted the expo in 2017 as well, offers an ideal location for the conference, which is designed to provide attendees with key information from the alternative-products space as well as invaluable networking opportunities. The event has become the largest expo series for all things vape, hemp and counterculture, and is a key gathering for smoke-shop owners, independent retailers, buyers, vendors and counterculture enthusiasts. The expo agenda includes presentations from key players in the field as well as access to new releases and high-quality products including vape, delta 8, hemp, CBD, disposables, kratom, mushrooms, functional beverages, nootropics, dietary supplements and much more. “Returning to beautiful Medellín is always very special for us at Alt Pro Expo,” said Alternative Products Expo brand manager Cesar Jimenez in the press release. “This is an incredibly diverse city and is home to some of the most incredible developments in the alternatives space. We have been very fortunate to channel these incredible resources and showcase a wide array of products and services to thousands of consumers and would-be consumers. We have always received wonderful support from the visiting crowds who have been key to making previous editions of Alt Pro Expo Medellín a resounding success. Our carefully designed environment offers excellent opportunities for relationship-building where attendees can educate themselves deeply about the sector, pick the brains of the finest industry experts and even explore potential synergies with numerous partners throughout the value chain. We encourage everyone from established industry professionals, avid customers, passionate community members and curious watchers to come and be a part of this unique conference.”

To view the full press release, visit https://cnw.fm/ote7X

About Alternative Products Expo

Alternative Products Expo, formerly USA CBD Expo, is a production of ZJ Events. Event founders were once exhibitors who, after attending countless trade show events, saw an opportunity to build upon their experience and create an event that combined the best they had seen with their own notion of what was missing in these business gatherings. By bringing the alternative community together, we seek to provide industry professionals from all corners of the market with an immersive and unique opportunity for networking and business expansion.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Twitter Makes Additional Concessions on Marijuana Advertising in US

Twitter has further relaxed its restrictions on marijuana advertising, allowing verified, state-legal companies to include packaged marijuana goods in their marketing campaigns and permitting ads in additional U.S. markets. According to a blog post by Alexa Alianiello, Twitter’s head of partnerships and sales, certified marijuana advertisers are now allowed to responsibly link to their websites and online stores that sell THC, CBD and marijuana-related goods and services.

Alianiello also stated that the platform has made changes for those with medical licenses and offered up more markets for recreational use, but there are some restrictions. Twitter’s publicly available drug ad policy does not state which new recreational and medical markets are now accessible to cannabis advertisements. However, the social media site is now allowing medical marijuana ads that target users in Florida, Alabama, Minnesota, Arkansas, Mississippi, Oklahoma, Missouri, Pennsylvania, Rhode Island, Puerto Rico, West Virginia and South Dakota, according to Mattio Communications CEO Rosie Mattio. The new adult-use cannabis market in Missouri will also be able to run cannabis ads.

In Mattio’s opinion, Twitter’s decision to allow images of packaged marijuana products allows these brands more potential to connect with consumers and inform them about the real product rather than just using the platform as a brand-recognition type of move. The privately owned social media site gave the nod to American marijuana advertising in February, a decision that was applauded by a lot of marijuana shareholders.

At the start, however, cannabis businesses reported conflicting outcomes when they attempted to market their products on Twitter. Lisa Buffo, CEO and founder of the Marijuana Marketing Association, says that she has witnessed all kinds of companies — big and small — attempt advertising with Twitter. Some have been approved, others have not, and others have had mixed results in the process. She goes on to say that advertising results vary and that a campaign’s and a brand’s success depends on how well they fit the platform.

In the blog post outlining the modifications to the ad policy, Alianiello stated that the company had received valuable input from the marijuana sector, which it had taken into account to expand opportunities. Twitter also accepts, subject to its restrictions, cannabis adverts directed at users in Thailand and Canada.

Other online platforms, including Alphabet, Google’s parent company, as well as Instagram, Facebook, and WhatsApp platforms run by Meta, generally forbid the promotion of marijuana products. However, Google does make an exception for some ads promoting CBD and hemp.

For entities such as IGC Pharma Inc. (NYSE American: IGC), whose focus is on developing FDA-approved treatments from cannabis, the rules on advertising marijuana set by Twitter and other such platforms are of little interest because there is a clear set of federal regulations governing how approved medicines can or cannot be advertised.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Florida Activists Close to Meeting Signature Goal to Qualify Marijuana Legalization Bill for Ballot

Cannabis advocates in the state of Florida have gathered 841,130 signatures for a ballot initiative to legalize cannabis. A poll published recently shows that 70% of residents in the state favor the idea of approving a constitutional amendment to enact marijuana legalization. Data released by the Florida Division of Elections estimates that the legalization campaign may soon reach the 891,523 signature mandate by the end of May.

Earlier this year, advocates had collected enough signatures to commence a state review by the Supreme Court regarding the text of the measure. By February’s end, the campaign had already surpassed 420,000 signatures with this figure rising to 635,961 by the end of March.

The state’s Supreme Court will focus on ensuring that the language of the legislation doesn’t mislead voters or violate the constitution’s single-subject rule. If the court rules that the measure meets the set standards, then the legalization campaign will only be required to submit enough signatures to qualify for the ballot.

Previous attempts to place adult-use legalization resolutions on the ballot have been rejected and/or challenged by the court, which opined that the text of proposed initiatives were misleading.

The state of Florida approved a medical marijuana constitutional amendment in 2016.

Smart&Safe Florida, the organization that filed the marijuana legislation last summer, is being sponsored almost entirely by Trulieve, the largest medical cannabis operator in Florida. Trulieve granted seed money that helped get the campaign going and is said to have contributed roughly $25 million to these efforts.

The bill’s approval will allow existing medical marijuana companies in the state to start selling cannabis to all individuals aged 21 years of age and older. It also contains a provision that would permit legislators to approve additional businesses that are not licensed marijuana dispensaries. Individuals aged 21 and older would be allowed to buy and possess no more than an ounce of marijuana, only 5g of which could be cannabis concentrate products.

However, the resolution excludes provisions such as relief for individuals with previous marijuana convictions and expungements. It should be noted that home growing by consumers would also not be permitted. The bill would take effect six months after it was approved by voters in Florida.

Meanwhile, advocates who aren’t directly involved in the campaign revealed in 2022 that they were looking into plans to have voters decide on what would be a complementary resolution that would allow adults to cultivate their own marijuana at home.

Opening up home cultivation of marijuana by adults would open up exciting opportunities for out-of-state enterprises such as Advanced Container Technologies Inc. (OTC: ACTX) that focus on making indoor cultivation equipment for high-value crops including cannabis.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.